Brain Neoplasms: Clinical Trials

134 trials for Brain Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

134 terminated. 134 Phase 2, 32 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2134Terminated 134
Phase 132Terminated 32

Follow Brain Neoplasms: new trials by email Literature Review of Brain Neoplasms trials Research Report on Brain Neoplasms

Trials (filtered) newest first · largest first

All 134 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases
Tiragolumab, Atezolizumab, Pemetrexed - Non-small Cell Lung Cancer
Phase 2TerminatedLiza Villaruz, MD32023-08-102026-01-22
Oral AMXT 1501 Dicaprate in Combination With IV DFMO
AMXT1501, DFMO - Cancer, Solid Tumor
Phase 1 / Phase 2TerminatedAminex Therapeutics, Inc.152022-11-292024-12-24
Pembro+Chemo in Brain Mets
Pembrolizumab, Nab paclitaxel, Paclitaxel - Lung Cancer, Lung Cancer Metastatic
Phase 2TerminatedJohn L. Villano, MD, PhD32022-05-192025-10-31
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
Pembrolizumab, Lenvatinib - Melanoma, Renal Cell Carcinoma
Phase 2TerminatedYale University182022-02-092026-06-04
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
Alectinib - Neoplasms, Colorectal Neoplasms
Phase 2TerminatedHoffmann-La Roche12021-05-242023-08-07
Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases
Glucocorticoid therapy - Brain Metastases, Adult
Phase 2TerminatedAHS Cancer Control Alberta22021-03-302025-06-27
Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
Bintrafusp Alfa, Pimasertib, Quality-of-Life Assessment - Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Phase 1 / Phase 2TerminatedM.D. Anderson Cancer Center82021-01-152026-03-18
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
Carboplatin, Etoposide, Atezolizumab - Small-cell Lung Cancer, Brain Metastases
Phase 2TerminatedJeffrey Clarke32021-01-052024-03-13
Brigatinib Before Brain Irradiation Trial (B3i Trial)
Brigatinib - Brain Metastases, Lung Cancer
Phase 2TerminatedUniversity of Colorado, Denver12020-11-172022-10-24
Neoadjuvant Immunotherapy in Brain Metastases
Nivolumab, Ipilimumab - Brain Metastases, Adult
Phase 2TerminatedSarah Sammons, MD12020-11-042022-07-26
Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Brain Metastases
AGuIX - Brain Metastases
Phase 2TerminatedCentre Leon Berard12020-01-172021-06-08
Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas
Capecitabine, Temozolomide - Recurrent Pituitary Adenomas
Phase 2TerminatedWeill Medical College of Cornell University12019-05-212022-08-09
Focal Intraoperative Radiotherapy of Brain Metastases
Intraoperative Radiotherapy - Brain Metastases, Adult, Central Nervous System Metastases
Phase 2TerminatedAC Camargo Cancer Center102019-05-022023-07-27
An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis
encorafenib, binimetinib - Brain Metastases
Phase 2TerminatedPfizer132019-04-302023-05-31
Sunitinib in Sarcomas of the Central Nervous System
Sunitinib, wGT3x-BT - Gliosarcoma, Central Nervous System Sarcoma
Phase 2TerminatedNational Cancer Institute (NCI)52019-02-212022-04-19
Seizure Prophylaxis in Patients With Glioma or Brain Metastasis
Lacosamide, Levetiracetam - Glioma, Glioma of Brain
Phase 2TerminatedDuke University42019-01-312023-04-13
A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT
Panobinostat - Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor
Phase 2TerminatedAustralian & New Zealand Children's Haematology/Oncology Group252019-01-092025-02-24
REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
cemiplimab (monotherapy), cemiplimab (maintenance), Conventional or hypofractionated - Relapsed Solid Tumor, Refractory Solid Tumor
Phase 1 / Phase 2TerminatedRegeneron Pharmaceuticals572018-09-242025-04-08
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
[18F]FLT, [18F]Fluciclovine - Brain Tumor
Phase 1 / Phase 2TerminatedUniversity of Utah102018-09-242024-12-27
Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases
Vemurafenib, Cobimetinib - Malignant Melanoma Stage IV, BRAF V600 Mutation
Phase 2TerminatedTechnische Universität Dresden202018-07-012023-09-14

Showing 20 of 134. Sign in to see all of them.

Narrower conditions

Glioblastoma (41)  ·  Glioma (28)  ·  Astrocytoma (19)  ·  Gliosarcoma (18)  ·  Melanoma (17)  ·  Neoplasm Metastasis (16)  ·  Breast Neoplasms (14)  ·  Carcinoma, Non-Small-Cell Lung (14)  ·  Central Nervous System Neoplasms (11)  ·  Lung Neoplasms (9)  ·  Oligodendroglioma (9)  ·  Diffuse Intrinsic Pontine Glioma (8)  ·  Neoplasms (7)  ·  Pituitary Neoplasms (7)

Broader conditions

Brain Diseases (134)  ·  Nervous System Diseases (134)  ·  Nervous System Neoplasms (134)  ·  Central Nervous System Diseases (133)  ·  Neoplasms by Site (133)  ·  Neoplasms (127)  ·  Central Nervous System Neoplasms (123)  ·  Neoplasms by Histologic Type (80)  ·  Neoplasms, Nerve Tissue (76)  ·  Neuroectodermal Tumors (76)  ·  Neoplasms, Germ Cell and Embryonal (74)  ·  Neoplasms, Glandular and Epithelial (64)  ·  Neoplasms, Neuroepithelial (59)  ·  Glioma (30)  ·  Pathological Conditions, Signs and Symptoms (27)

Interventions

Temozolomide (21)  ·  Bevacizumab (10)  ·  Radiotherapy (7)  ·  Capecitabine (5)  ·  Carboplatin (4)  ·  Erlotinib Hydrochloride (4)  ·  Nivolumab (4)  ·  Radiation (4)  ·  Radiosurgery (4)  ·  Sunitinib (4)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (3)  ·  Ipilimumab (3)  ·  Mental Status and Dementia Tests (3)  ·  Pemetrexed (3)  ·  Topotecan (3)

Sponsors

National Cancer Institute (NCI) (12)  ·  M.D. Anderson Cancer Center (5)  ·  Duke University (4)  ·  Novartis Pharmaceuticals (4)  ·  Alliance for Clinical Trials in Oncology (3)  ·  AHS Cancer Control Alberta (2)  ·  Case Comprehensive Cancer Center (2)  ·  Children's Hospital Medical Center, Cincinnati (2)  ·  GlaxoSmithKline (2)  ·  H. Lee Moffitt Cancer Center and Research Institute (2)  ·  Liza Villaruz, MD (2)  ·  Merck Sharp & Dohme LLC (2)  ·  Methodist Healthcare - Memphis (2)  ·  OHSU Knight Cancer Institute (2)  ·  University College, London (2)

Countries

United States (105)  ·  Canada (13)  ·  Germany (8)  ·  Italy (7)  ·  Spain (7)  ·  Australia (6)  ·  Belgium (6)  ·  France (5)  ·  Netherlands (5)  ·  Brazil (4)  ·  United Kingdom (4)  ·  Argentina (3)  ·  Mexico (3)  ·  Greece (2)  ·  Switzerland (2)

Top investigators

Allen K Sills, MD (2)  ·  Edward Pan, MD (2)  ·  Hamidreza Aliabadi, MD (2)  ·  Howard A Fine, M.D. (2)  ·  James E. Herndon, PhD (2)  ·  John H. Sampson, MD, PhD (2)  ·  John P. Kirkpatrick, MD (2)  ·  Adrienne C Scheck, PhD (1)  ·  Annick Desjardins, M.D. (1)  ·  Anthony Brade, M.D. (1)  ·  Anthony Heaney, MD (1)  ·  Arjun Sahgal (1)  ·  Ashley Sumrall, MD (1)

Results publications

PMID 12749708, PMID 16648043, PMID 20042969, PMID 21865400, PMID 22198309, PMID 27232884, PMID 29741745, PMID 31401903, PMID 31776899, PMID 32270710, PMID 32354716, PMID 32603316, PMID 33034839, PMID 34359048, PMID 34540703, PMID 36705597, PMID 37876540, PMID 40721826

NIH funding

2009 (3), 2015 (2), U01CA137443 (2), 2008 (1), 2016 (1), 2017 (1), 2018 (1), N01CM00039 (1), P30CA014236 (1), P30CA016672 (1), P30CA033572 (1), P30CA043703 (1), P30CA046934 (1), P30CA124435 (1), P50NS020023 (1)